Abstract
Environmental and/or occupational factors have been proposed to play a critical role in urological malignancies and, in particular, in bladder cancer. Epidemiological studies have demonstrated with sufficient evidence that factors such as smoking and exposure to aromatic amines, paints and solvents, leather dust, inks, some metals, polycyclic aromatic hydrocarbons, combustion products, or diesel exhaust fumes are associated with the development of bladder cancer. Candidates with an uncertain potential for inducing this type of cancer include dietary factors, specifically fats and cholesterol, and the exposure to contaminants in drinking water. This chapter will describe and discuss the respective literature on environmental and occupational factors linked to carcinogenesis in bladder cancer. For several reasons, the potential effects of tea and coffee consumption will also be considered. A solid epidemiological evaluation of environmental and occupational factors linked to carcinogenesis has to meet many challenges: the number of confounding factors is often large, exposure needs to be determined retrospectively, and elevation of the attributable risk is low in most cases. In view of the long-term exposure of the vast majority of the population to, for instance, drinking- water contaminants, however, the impact of even small elevations of risk warrants evaluation. This complex task needs comprehensive approaches on a large scale including modern analytical, molecular biological and epidemiological methods.
Similar content being viewed by others
References
Rehn L (1895) Blasengeschwülste bei Fuchsin-Arbeitern. Arch Klin Chi 50:588–600
Doll R, Peto R (1981) The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 66:1191–1308
Rook JJ (1974) Formation of haloforms during chlorination of natural waters. J Soc Water Treat Exam 23:234–243
Bellar TA, Lichtenberg JJ, Kroner RC (1974) The occurence of organohalides in chlorinated drinking waters. J Am Water Works Assoc 66:703–706
Symons JM, Bellar TA, Carswell JK (1975) National organics reconnaissance survey for halogenated organics in drinking water. J Am Water Works Assoc 67:634–674
International Agency for Research on Cancer (1991b) Chlorinated drinking-water; chlorination by-products; some other halogenated compounds; cobalt and cobalt compounds. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol 52. IARC, Lyon
Bull RJ, Sanchez IM, Nelson MA, et al. (1990) Liver tumor induction in B6C3F1 mice by dichloroacetate and trichloroacetate. Toxicology 63:341–359
Komulainen H, Kosma VM, Vaittinen SL et al. (1997) Carcinogenicity of the drinking water mutagen 3-chloro-4- (dichloromethyl)-5-hydroxy-2(5H)-furanone in the rat. J Natl Cancer Inst 89:848–856
Matsumura H, Watanabe M, Matsumoto K, et al. (1994) 3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) induces gene mutations and inhibits metabolic cooperation in cultured Chinese hamster cells. J Toxicol Environ Health 43:65–72
Thomas EL, Jefferson MM, Bennett JJ, Learn DB (1987) Mutagenic activity of chloramines. Mutat Res 188:35–43
Dunnick JK, Melnick RL (1993) Assessment of the carcinogenic potential of chlorinated water: experimental studies of chlorine, chloramine, and trihalomethanes. Assessment of the carcinogenic potential of chlorinated water: experimental studies of chlorine, chloramine, and trihalomethanes. J Natl Cancer Inst 85:817–822
Kurokawa Y, Hayashi Y, Maekawa A, Takahashi M, Kokubo T, Odashima S (1983) Carcinogenicity of potassium bromate administered orally to F344 rats. J Natl Cancer Inst 71:965–972
Stauber AJ, Bull RJ (1997) Differences in phenotype and cell replicative behavior of hepatic tumors induced by dichloroacetate (DCA) and trichloroacetate (TCA). Toxicol Appl Pharmacol 144:235–246
US Federal Register (1994) 59:38765
Wagner HP, Pepich BV, Hautman DP, Munch DJ (2000) Eliminating the chlorite interference in US Environmental Protection Agency Method 317.0 permits analysis of trace bromate levels in all drinking water matrices. J Chromatogr A 882:309–319
Von Gunten U (2003) Ozonation of drinking water: part II. Disinfection and by-product formation in presence of bromide, iodide or chlorine. Water Res 37:1469-1487
Bucher JR, Hejtmancik MR, Toft JD, Persing RL, Eustis SL, Haseman JK (1991) Results and conclusions of the National Toxicology Program’s rodent carcinogenicity studies with sodium fluoride. Int J Cancer 48:733–734
Cohn P (1993) Osteosarcoma and chlorinated drinking water. US Department of Health, Trenton
Wang M, Wang Z, Ran L, Han H (2003) Study on food contaminants monitoring in China during 2000–2001. Wei Sheng Yan Jiu 32:322–326
Chen YC, Su HJ, Guo YL, Hsueh YM, Smith TJ, Ryan LM, Lee MS, Christiani DC (2003) Arsenic methylation and bladder cancer risk in Taiwan. Cancer Causes Control 14:303–310
Chiou HY, Chiou ST, Hsu YH, Chou YL, Tseng CH, Wei ML, Chen CJ (2001) Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am J Epidemiol 153:411–418
Hopenhayn-Rich C, Biggs ML, Smith AH (1998) Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, Argentina. Int J Epidemiol 27:561–569
Smith AH, Goycolea M, Haque R, Biggs ML (1998) Marked increase in bladder and lung cancer mortality in a region of northern Chile due to arsenic in drinking water. Am J Epidemiol 147:660–669
Cuzick J, Sasieni P, Evans S (1992) Ingested arsenic, keratoses, and bladder cancer. Am J Epidemiol 136:417–421
Kasper ML, Schoenfield L, Strom RL, Theologides A (1984) Hepatic angiosarcoma and bronchioloalveolar carcinoma induced by Fowler’s solution. JAMA 252:3407–3408
Tsuda T, Nagira T, Yamamoto M, Kume Y (1990) An epidemiological study on cancer in certified arsenic poisoning patients in Toroku. Ind Health 28:53–62
Cantor KP (1997) Drinking water and cancer. Cancer Causes Control 8:292–308
Hinwood AL, Sim MR, Jolley D, de Klerk N, Bastone EB, Gerostamoulos J, Drummer OH (2003) Risk factors for increased urinary inorganic arsenic concentrations from low arsenic concentrations in drinking water. Int J Environ Health Res 13:271–284
Smith E, Smith J, Smith L, Biswas T, Correll R, Naidu R (2003) Arsenic in Australian environment: an overview. J Environ Sci Health Part A Tox Hazard Subst Environ Eng 38:223–239
Nakadaira H, Nakamura K, Mutoh K, Yamamoto M, Katoh K (2000) Arsenic residues in well water 36 y after endemic arsenic poisoning. Arch Environ Health 55:364
Gomez-Arroyo S, Armienta MA, Cortes-Eslava J, Villalobos-Pietrini R (1997) Sister chromatid exchanges in Vicia faba induced by arsenic-contaminated drinking water from Zimapan, Hidalgo, Mexico. Mutat Res 394:1–7
Wyatt CJ, Fimbres C, Romo L, Mendez RO, Grijalva M (1998) Incidence of heavy metal contamination in water supplies in northern Mexico. Environ Res 76:114–119
Chongsuvivatwong V, Lim A, Dueravee M, Geater A, Ritsamitchai S, Oshikawa S (2000) Follow up of water use in a tin mining area affected with arsenic poisoning. Southeast Asian J Trap Med Public Health 31:769–774
Khan MM, Sakauchi F, Sonoda T, Washio M, Mori M (2003) Magnitude of arsenic toxicity in tube-well drinking water in Bangladesh and its adverse effects on human health including cancer: evidence from a review of the literature. Asian Pac J Cancer Prev 4:7–14
Harvey CF, Swartz CH, Badruzzaman AB, Keon-Blute N, Yu W, An MA, Jay J, Beckie FT, Niedan V, Brabander D, Oates PM, Ashfaque KN, Islam S, Hemond HF, Ahmed MF (2002) Arsenic mobility and groundwater extraction in Bangladesh. Science 298:1602–1606
Rahman M (2003) The Bangladesh arsenic catastrophe: clinical manifestations. Trop Doct 33:42–44
Anawar HM, Akai J, Mostofa KM, Safiullah S, Tareq SM (2002) Arsenic poisoning in groundwater: health risk and geochemical sources in Bangladesh. Environ Int 27:597–604
Das D, Chatterjee A, Samanta G, Mandal B, Chowdhury TR, Samanta G, Chowdhury PP, Chanda C, Basu G, Lodh D et al. (1994) Arsenic contamination in groundwater in six districts of West Bengal, India: the biggest arsenic calamity in the world. Analyst 119:168–170
Das D, Chatterjee A, Mandal BK, Samanta G, Chakraborti D, Chanda B (1995) Arsenic in ground water in six districts of West Bengal, India: the biggest arsenic calamity in the world. Part 2. Arsenic concentration in drinking water, hair, nails, urine, skin-scale and liver tissue (biopsy) of the affected people. Analyst 120:917–924
Berg M, Tran HC, Nguyen TC, Pham HV, Schertenleib R, Giger W (2001) Arsenic contamination of groundwater and drinking water in Vietnam: a human health threat. Environ Sci Technol 35:2621–2626
Bates MN, Smith AH, Cantor KP (1995) Case-control study of bladder cancer and arsenic in drinking water. Am J Epidemiol 141:523–530
Kurttio P, Pukkala E, Kahelin H, Auvinen A, Pekkanen J (1999) Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. Environ Health Persp 107:705–710
IARC Monographs (1980) 23:39–141
IARC Monographs (1987) [Suppl 6]:71–76
Simeonova PP, Luster Ml (2000) Mechanisms of arsenic carcinogenicity: genetic or epigenetic mechanisms? J Environ Pathol Toxicol Oncol 19:281–286
Mass MJ, Tennant A, Roop BC, Cullen WR, Styblo M, Thomas DJ, Kligerman AD (2001) Methylated trivalent arsenic species are genotoxic. Chem Res Toxicol 14:355–361
Moore LE, Smith AH, Eng C, Kalman D, DeVries S, Bhargava V, Chew K, Moore D2nd, Ferreccio C, Rey OA, Waldman FM (2002) Arsenic-related chromosomal alterations in bladder cancer. J Natl Cancer Inst 94:1688-1696
National Academy of Science—National Research Council Academy of Life Science (1981) The health effects of nitrate, nitrite, and N-nitroso compounds. National Academy of Science Press, Washington DC
Tricker AR, Preussmann R (1991) Carcinogenic N-nitrosamines in the diet: occurrence, formation, mechanisms and carcinogenic potential. Mutat Res 259:277–289
Abdel Mohsen MA, Hassan AA, El-Sewedy SM, Aboul-Azm T, Magagnotti C, Fanelli R, Airoldi L (1999) Biomonitoring of n-nitroso compounds, nitrite and nitrate in the urine of Egyptian bladder cancer patients with or without Schistosoma haematobium infection. Int J Cancer 82:789–794
Bartsch H, Ohshima H, Pignatelli B, Calmeis S (1989) Human exposure to endogenous N-nitroso compounds: quantitative estimates in subjects at high risk for cancer of the oral cavity, oesophagus, stomach and urinary bladder. Cancer Surv 8:335–362
Sheweita SA, Mubark J, Doenhofe MJ, Mostafa MH, Margison GP, O’Connor PJ, Elder RH (2002) Changes in the expression of cytochrome P450 isozymes and related carcinogen metabolizing enzyme activities in Schistosoma mansoni-infected mice. J Helminthol 76:71–78
Ward MH, Cantor KP, Riley D, Merkle S, Lynch CF (2003) Nitrate in public water supplies and risk of bladder cancer. Epidemiology 14:183–190
McGeehin MA, Reif JS, Becher JC, Mangione EJ (1993) Case-control study of bladder cancer and water disinfection methods in Colorado. Am J Epidemiol 138:492–501
Weyer PJ, Cerhan JR, Kross BC, Hallberg GR, Kantamneni J, Breuer G, Jones MP, Zheng W, Lynch CF (2001) Municipal drinking water nitrate level and cancer risk in older women: the Iowa Women’s Health Study. Epidemiology 12:327-338
Morales Suarez-Varela M, Llopis Gonzalez A, Tejerizo Perez ML, Ferrandiz Ferragud J (1993) Concentration of nitrates in drinking water and its relationship with bladder cancer. J Environ Pathol Toxicol Oncol 12:229–236
Morales-Suarez-Varela MM, Llopis-Gonzalez A, Tejerizo-Perez ML (1995) Impact of nitrates in drinking water on cancer mortality in Valencia, Spain. Eur J Epidemiol 11:15–21
Gulis G, Czompolyova M, Cerhan JR (2002) An ecologic study of nitrate in municipal drinking water and cancer incidence in Trnava District, Slovakia. Environ Res 88:182–187
Darewicz G, Malczyk E, Darewicz J (1998) Investigations of urinary cadmium content in patients with urinary bladder carcinoma. Int Urol Nephrol 30:137–139
Siemiatycki J, Dewar R, Nadon L, Gerin M (1994) Occupational risk factors for bladder cancer: results from a case-control study in Montreal, Quebec, Canada. Am J Epidemiol 140:1061–1080
Louekari K (1992) Estimation of dietary intake of cadmium: reliability of methods. IARC Sci Publ 118:163–167
Langard S (1994) Nickel-related cancer in welders. Sci Total Environ 148:303–309
Hours M, Cardis E, Marciniak A, Quelin P, Fabry J (1989) Mortality of a cohort in a polyamide-polyester factory in Lyon: a further follow up. Br J Ind Med 46:665–670
Gustavsson P, Gustavsson A, Hogstedt C (1988) Excess of cancer in Swedish chimneysweeps. Br J Ind Med 45:777–781
Isacson P, Bean JA, Splinter R, Olson DB, Kohler J (1985) Drinking water and cancer incidence in Iowa. III. Association of cancer with indices of contamination. Am J Epidemiol 121:856–869
Pavlova L, Saydacova N, Startzeva L (2001) The state of urologic assistance for the population of Ukraine and the ways to improve it. Ukrainian Ministry of Health. Annual Reports of the Health Care in Ukraine, pp 214–243
Yamamoto S, Romanenko A, Wei M, Masuda C, Zaparin W, Vinnichenko W, Vozianov A (1999) Specific p53 gene mutations in urinary bladder epithelium after the Chernobyl accident. Cancer Res 59:3606–3609
De Vathaire F, De Vathaire CC, Ropers J, Mollie A (1998) Cancer mortality in the commune of Pargny sur Saulx in France. J Radiol Prot 18:23–27
Bean JA, Isacson P, Hahne RM, Kohler J (1982) Drinking water and cancer incidence in Iowa. II. Radioactivity in drinking water. Am J Epidemiol 116:924–932
US Environmental Protection Agency (1991)
Weiss NS (1995) Cancer in relation to occupational exposure to perchloroethylene. Cancer Causes Control 6:257–266
Ruder AM, Ward EM, Brown DP (1994) Cancer mortality in female and male dry-cleaning workers. J Occup Med 36:867–874
Aschengrau A, Ozonoff D, Paulu C, Coogan P, Vezina R, Heeren T, Zhang Y (1993) Cancer risk and tetrachloroethylene-contaminated drinking water in Massachusetts. Arch Environ Health 48:284–292
Nieuwenhuijsen MJ, Toledano MB, Eaton N et al. (2000) Chlorination disinfection by-products in water and their association with adverse reproductive outcomes: a review. Occup Environ Med 57:73–85
Villanueva CM, Kogevinas M, Grimalt JO (2001) Cloracion del agua potable y efectos sobre la salud: revision de estudios epidemiologicos. Med Clin 117:27–35.
Koivusalo M, Hakulinen T, Vartiainen T, et al. (1998) Drinking water mutagenicity and urinary tract cancers: a population-based case-control study in Finland. Am J Epidemiol 148:704–712
International Programme on Chemical Safety (IPCS). Disinfectant and disinfectant by-products. Environmental Health Criteria 216. United Nations Environment Programme, International Labour Organization, World Health Organization, Geneva
McGeehin MA, Reif JS, Becher JC et al. (1993) Case-control study of bladder cancer and water disinfection methods in Colorado. Am J Epidemiol 138:492–501
King WD, Marrett LD (1996) Case-control study of bladder cancer and chlorination by-products in treated water (Ontario, Canada). Cancer Causes Control 7:596–604
Cantor KP, Lynch CF, Hildesheim ME et al. (1998) Drinking water source and chlorination by-products. I. Risk of bladder cancer. Epidemiology 9:21–28
Morris RD, Audet AM, Angelillo IF, Chalmers TC, Mosteller F (1993) Chlorination, chlorination by-products, and cancer: a meta-analysis. Am J Public Health 83:1257
Bove F, Shim Y, Zeitz P (2002) Drinking water contaminants and adverse pregnancy outcomes: a review. Environ Health Perspect 110 [Suppl 1]:61–74
IARC. Some chemicals that cause tumors of the kidney or urinary bladder in rodents and some other substances, vol 73. IARC monographs on the evaluation of carcinogenic risks to humans. IARC, Lyon
Moher D, Cook DJ, Eastwood S et al. (2002) Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 354:1896–1900
Villanueva CM, Fernandez F, Malats N, Grimalt JO, Kogevinas M (2003) Meta-analysis of studies on individual consumption of chlorinated drinking water and bladder cancer. J Epidemiol Community Health 57:166–173
Cantor KP, Hoover R, Hartge P et al. (1987) Bladder cancer, drinking water source, and tap water consumption: a case-control study. J Natl Cancer Inst 79:1269–1279
Vena JE, Graham S, Freudenheim J et al. (1993) Drinking water, fluid intake, and bladder cancer in western New York. Arch Environ Health 48:191–198
Wilkins JR, Comstock GW (1981) Source of drinking water at home and site- specific cancer incidence in Washington County, Maryland. Am J Epidemiol 114:178–190
Doyle TJ, Zheng W, Cerhan JR et al. (1997) The association of drinking water source and chlorination by-products with cancer incidence among postmenopausal women in Iowa: a prospective cohort study. Am J Public Health 87:1168–1176
Jo WK, Weisel CP, Lioy PJ (1990) Chloroform exposure and the health risk associated with multiple uses of chlorinated tap water. Risk Anal 10:581–585
Jo WK, Weisel CP, Lioy PJ (1990) Routes of chloroform exposure and body burden from showering with chlorinated tap water. Risk Anal 10:575–580
Backer LC, Ashley DL, Bonin MA et al. (2000) Household exposures to drinking water disinfection by-products: whole blood trihalomethane levels. J Expo Anal Environ Epidemiol 10:321–316
Levesque B, Ayotte P, LeBlanc A, Dewailly E, Prud’Homme D, Lavoie R, Allaire S, Levallois P (1994) Evaluation of dermal and respiratory chloroform exposure in humans. Environ Health Perspect 102:1082–1087
Woo YT, Lai D, McLain JL, Manibusan MK, Dellarco V (2002) Use of mechanism-based structure-activity relationships analysis in carcinogenic potential ranking for drinking water disinfection by-products. Environ Health Perspect 110 [Suppl 1]:75–87
Stensvold I, Jacobsen BK (1994) Coffee and cancer: a prospective study of 43,000 Norwegian men and women. Cancer Causes Control 5:401–408
Mills P, Beeson WL, Phillips RL, Fraser GE (1991) Bladder cancer in a low risk population: results from the Adventist Health Study. Am J Epidemiol 133:230–239
Clavel J, Cordier S (1991) Coffee consumption and bladder cancer risk. Int J Cancer 47:207–212
Viscoli CM, Lachs MS, Horwitz Rl (1993) Bladder cancer and coffee drinking: a summary of case-control research. Lancet 341:1432–1437
Momas I, Daures JP, Festy B, Bontoux J, Gremy F (1994) Bladder cancer and black tobacco cigarette smoking. Some results from a French case-control study. Eur J Epidemiol 10:599–604
Sala M, Cordier S, Chang-Claude J, Donato F, Escolar-Pujolar A, Fernandez F et al. (2000) Coffee consumption and bladder cancer in non-smokers: a pooled analysis of case-control studies in European countries. Cancer Causes Control 11:925–931
IARC (1991) Coffee, tea, mate, methylxanthines and methylglyoxal. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, vol 51. IARC, Lyon
Michaud DS, Spiegelman D, Clinton SK, Rimm EB, Curhan GC, Willett WC et al. (1999) Fluid intake and the risk of bladder cancer in men. N Engl J Med 340:1390–1397
Ivankovic S, Seibel J, Komitowski D, Spiegelhalder B, Preussmann R, Siddiqi M (1998) Caffeine-derived N-nitroso compounds. V. Carcinogenicity of mononitrosocaffeidine and dinitrosocaffeidine in bd-ix rats. Carcinogenesis 19:933–937
Cui X, Guo R, Xu Z, Wang B, Li C (2000) Relationship between metabolic phenotype of N-acetylation and bladder cancer. Chin Med J 113:303–305
Chung FL, Wang M, Rivenson A, latropoulos MJ, Reinhardt JC, Pittman B, Ho CT, Amin SG (1998) Inhibition of lung carcinogenesis by black tea in Fischer rats treated with a tobacco-specific carcinogen: caffeine as an important constituent. Cancer Res 58:4096–4101
Blasina A, Price BD, Turenne GA, McGowan CH (1999) Caffeine inhibits the checkpoint kinase ATM. Curr Biol 9:1135–1138
Roy M, Siddiqi M, Bhattacharya RK (2001) Cancer chemoprevention: tea polyphenol induced cellular and molecular responses. Asian Pac J Cancer Prev 2:109–116
Roy M, Chakrabarty S, Sinha D, Bhattacharya RK, Siddiqi M (2003) Anticlastogenic, antigenotoxic and apoptotic activity of epigallocatechin gallate: a green tea polyphenol. Mutat Res 523–524:33–41
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Goebell, P.J., Villanueva, C.M., Rettenmeier, A.W. et al. Environmental exposure, chlorinated drinking water, and bladder cancer. World J Urol 21, 424–432 (2004). https://doi.org/10.1007/s00345-003-0389-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-003-0389-1